Cyclopharm Ltd
ASX:CYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cyclopharm Ltd
Cash Interest Paid
Cyclopharm Ltd
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash Interest Paid
-AU$626.3k
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-38%
|
|
|
Somnomed Ltd
ASX:SOM
|
Cash Interest Paid
-AU$70.6k
|
CAGR 3-Years
51%
|
CAGR 5-Years
32%
|
CAGR 10-Years
-16%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash Interest Paid
-AU$11.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Cash Interest Paid
-AU$11k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash Interest Paid
-AU$15.3k
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Cyclopharm Ltd
Glance View
Cyclopharm Ltd. is a radiopharmaceutical company, which engages in the diagnostic imaging in lung health. The company provides diagnostic imaging services specializing in lung health. The firm through its medical device and pharmaceutical products under the name of Technegas, which has become the industry in diagnostic functional lung imaging technology. The company distributes its products in approximately 60 countries throughout the world with over 1500 nuclear medicine departments utilizing Technegas. The firm formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Macquarie Medical Imaging (MMI) offers a range of diagnostic radiology, interventional radiology, nuclear medicine and molecular imaging services for inpatient and outpatients. Its Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.
See Also
What is Cyclopharm Ltd's Cash Interest Paid?
Cash Interest Paid
-626.3k
AUD
Based on the financial report for Dec 31, 2025, Cyclopharm Ltd's Cash Interest Paid amounts to -626.3k AUD.
What is Cyclopharm Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
-38%
Over the last year, the Cash Interest Paid growth was -96%. The average annual Cash Interest Paid growth rates for Cyclopharm Ltd have been -33% over the past three years , -25% over the past five years , and -38% over the past ten years .
